Outcomes for COPD pharmacological trials: From lung function to biomarkers;Avaliação dos resultados nos ensaios clínicos na DPOC: Da função pulmonar aos marcadores biológicos

Revista Portuguesa de Pneumologia

Volumn 14, Issue 4, 2008, Pages 579-583

  Cazzola, M ^a   MacNee, W ^a   Martinez, F J ^a   Rabe, K F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRONCHODILATING AGENT; PROTEIN C;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; ENDURANCE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MEDICAL LITERATURE; MEDICAL SOCIETY; MORTALITY; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; SHORT SURVEY; SOCIOECONOMICS; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

EID: 48349108860     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30266-x     Document Type: Short Survey

References (10)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report (Updated 2007). www.goldcopd.org. Último acesso em 21-05-2008.
2. Bergner M. The sickness impact profile. In Walker SR, ed., Quality of Life: Assessment and Application. Boston, MTP, 1987: 79-94.
3. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-8.
4. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic air-flow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-7.
5. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000; 94: 589-96.
6. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581-6.
7. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-8.
8. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81.
9. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005; 26: 630-6.
10. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-7.